Literature DB >> 7871763

Molecular characterization and determination of the coding capacity of the genome of equine herpesvirus type 2 between the genome coordinates 0.235 and 0.258 (the EcoRI DNA fragment N; 4.2 kbp).

H J Rode1, J J Bugert, M Handermann, P Schnitzler, R Kehm, W Janssen, H Delius, G Darai.   

Abstract

The complete DNA nucleotide sequence of the EcoRI DNA fragment N (0.235 to 0.258 viral map units) of equine herpes virus type 2 (EHV-2) strain T400/3 was determined. This DNA fragment comprises 4237 bp with a base composition of 55.23% G+C and 44.77% A+T. Nineteen open reading frames (ORFs) of 50-287 amino acid (aa) residues were detected. ORF number 10 is located between the nucleotide position 2220 and 2756 coding for a protein of 179 amino acid residues. This protein shows significant homology to the cytokine synthesis inhibitory factor (CSIF; interleukin 10) of human (76.4%) and mouse (68.5%), and to the Epstein-Barr virus (EBV) protein BCRF1 (70.6%). The existence of an interleukin 10 (IL-10) analogous gene within the genome of the EHV-2 was confirmed by screening the genome of nine EHV-2 strains using specific oligonucleotide primers corresponding to the 5' and 3' region of this particular gene by polymerase chain reaction. In all experiments an 870 bp DNA product was amplified. The specifity of the amplified DNA fragments obtained from individual EHV-2 strains was confirmed by DNA-DNA hybridization experiments. The DNA sequence analysis of the amplified DNA products of the EHV-2 strain LK was carried out. This analysis revealed the identity of the corresponding IL-10 gene (540 bp) of this strain to the IL-10 gene of EHV-2 strain T400/3. The presented data indicate that the EHV-2 genome harbors a viral interleukin 10-like gene. This is further evidence that the IL-10 gene can be present in the genomes of members of the Herpesviridae family.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7871763     DOI: 10.1007/bf01703436

Source DB:  PubMed          Journal:  Virus Genes        ISSN: 0920-8569            Impact factor:   2.332


  53 in total

Review 1.  Virus proteins that counteract host immune defenses.

Authors:  L R Gooding
Journal:  Cell       Date:  1992-10-02       Impact factor: 41.582

2.  Two vaccinia virus proteins structurally related to the interleukin-1 receptor and the immunoglobulin superfamily.

Authors:  G L Smith; Y S Chan
Journal:  J Gen Virol       Date:  1991-03       Impact factor: 3.891

3.  DNA nucleotide sequence analysis of the PvuII DNA fragment L of the genome of insect iridescent virus type 6 reveals a complex cluster of multiple tandem, overlapping, and interdigitated repetitive DNA elements.

Authors:  M Fischer; P Schnitzler; J Scholz; A Rösen-Wolff; H Delius; G Darai
Journal:  Virology       Date:  1988-12       Impact factor: 3.616

4.  Studies on equine herpesviruses. 5. Isolation and characterisation of slowly cytopathic equine herpesviruses in Queensland.

Authors:  T J Harden; T J Bagust; R R Pascoe; P B Spradbrow
Journal:  Aust Vet J       Date:  1974-11       Impact factor: 1.281

5.  Evidence of respiratory tract infection induced by equine herpesvirus, type 2, in the horse.

Authors:  J R Blakeslee; R G Olsen; E S McAllister; J Fassbender; R Dennis
Journal:  Can J Microbiol       Date:  1975-12       Impact factor: 2.419

6.  Homology of cytokine synthesis inhibitory factor (IL-10) to the Epstein-Barr virus gene BCRFI.

Authors:  K W Moore; P Vieira; D F Fiorentino; M L Trounstine; T A Khan; T R Mosmann
Journal:  Science       Date:  1990-06-08       Impact factor: 47.728

7.  Differential interleukin-2 and interferon-gamma production by human lymphocyte cultures exceptionally resistant to Epstein-Barr virus immortalization.

Authors:  J Gosselin; J Menezes; G Mercier; G Lamoureux; D Oth
Journal:  Cell Immunol       Date:  1989-09       Impact factor: 4.868

8.  Physical mapping of a genome of equine herpesvirus 2 (equine cytomegalovirus).

Authors:  G F Browning; M J Studdert
Journal:  Arch Virol       Date:  1989       Impact factor: 2.574

9.  Identification and characterization of the repetitive DNA element in the genome of insect iridescent virus type 6.

Authors:  M Fischer; P Schnitzler; H Delius; G Darai
Journal:  Virology       Date:  1988-12       Impact factor: 3.616

10.  Lymphokine-mediated regulation of the proliferative response of clones of T helper 1 and T helper 2 cells.

Authors:  R Fernandez-Botran; V M Sanders; T R Mosmann; E S Vitetta
Journal:  J Exp Med       Date:  1988-08-01       Impact factor: 14.307

View more
  7 in total

Review 1.  Herpesvirus homologues of cellular genes.

Authors:  M Raftery; A Müller; G Schönrich
Journal:  Virus Genes       Date:  2000       Impact factor: 2.332

2.  A homolog of interleukin-10 is encoded by the poxvirus orf virus.

Authors:  S B Fleming; C A McCaughan; A E Andrews; A D Nash; A A Mercer
Journal:  J Virol       Date:  1997-06       Impact factor: 5.103

3.  Epstein-Barr virus LMP2A increases IL-10 production in mitogen-stimulated primary B-cells and B-cell lymphomas.

Authors:  Ryan Incrocci; Molly McCormack; Michelle Swanson-Mungerson
Journal:  J Gen Virol       Date:  2013-01-09       Impact factor: 3.891

Review 4.  Poxvirus homologues of cellular genes.

Authors:  J J Bugert; G Darai
Journal:  Virus Genes       Date:  2000       Impact factor: 2.198

5.  The EBV immunoevasins vIL-10 and BNLF2a protect newly infected B cells from immune recognition and elimination.

Authors:  Simon Jochum; Andreas Moosmann; Stephan Lang; Wolfgang Hammerschmidt; Reinhard Zeidler
Journal:  PLoS Pathog       Date:  2012-05-17       Impact factor: 6.823

6.  Equine Transport and Changes in Equid Herpesvirus' Status.

Authors:  Katharine E Muscat; Barbara Padalino; Carol A Hartley; Nino Ficorilli; Pietro Celi; Peter Knight; Sharanne Raidal; James R Gilkerson; Gary Muscatello
Journal:  Front Vet Sci       Date:  2018-09-25

Review 7.  Cytokine-Targeted Therapeutics for KSHV-Associated Disease.

Authors:  Nedaa Alomari; Jennifer Totonchy
Journal:  Viruses       Date:  2020-09-28       Impact factor: 5.048

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.